Foreign Generic Drug Manufacturing: FDA Oversight, New Unannounced Inspections, and Standards
Explore how the FDA is tightening oversight of foreign generic drug manufacturing with new unannounced inspections, addressing cGMP compliance gaps and ensuring patient safety.
13 Jul 2026